vs

Side-by-side financial comparison of CHOICEONE FINANCIAL SERVICES INC (COFS) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

CHOICEONE FINANCIAL SERVICES INC is the larger business by last-quarter revenue ($42.9M vs $37.2M, roughly 1.2× Organogenesis Holdings Inc.). On growth, CHOICEONE FINANCIAL SERVICES INC posted the faster year-over-year revenue change (76.4% vs -57.1%). Over the past eight quarters, CHOICEONE FINANCIAL SERVICES INC's revenue compounded faster (15.0% CAGR vs -46.5%).

ChoiceOne Financial Services Inc is a US regional financial holding company that operates through its banking subsidiary, offering personal and commercial banking products including savings accounts, loans, wealth management, and insurance services primarily to consumers, small businesses, and corporate clients across Michigan.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

COFS vs ORGO — Head-to-Head

Bigger by revenue
COFS
COFS
1.2× larger
COFS
$42.9M
$37.2M
ORGO
Growing faster (revenue YoY)
COFS
COFS
+133.4% gap
COFS
76.4%
-57.1%
ORGO
Faster 2-yr revenue CAGR
COFS
COFS
Annualised
COFS
15.0%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
COFS
COFS
ORGO
ORGO
Revenue
$42.9M
$37.2M
Net Profit
Gross Margin
30.8%
Operating Margin
39.1%
-185.1%
Net Margin
Revenue YoY
76.4%
-57.1%
Net Profit YoY
EPS (diluted)
$1.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COFS
COFS
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$42.9M
$225.6M
Q3 25
$61.8M
$150.9M
Q2 25
$60.4M
$101.0M
Q1 25
$44.9M
$86.7M
Q4 24
$24.3M
$126.7M
Q3 24
$36.6M
$115.2M
Q2 24
$34.0M
$130.2M
Net Profit
COFS
COFS
ORGO
ORGO
Q1 26
Q4 25
$43.7M
Q3 25
$14.7M
$21.6M
Q2 25
$13.5M
$-9.4M
Q1 25
$-13.9M
$-18.8M
Q4 24
$7.7M
Q3 24
$7.3M
$12.3M
Q2 24
$6.6M
$-17.0M
Gross Margin
COFS
COFS
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
COFS
COFS
ORGO
ORGO
Q1 26
-185.1%
Q4 25
39.1%
28.1%
Q3 25
29.6%
13.7%
Q2 25
27.6%
-12.5%
Q1 25
-39.2%
-30.9%
Q4 24
36.1%
8.1%
Q3 24
25.4%
5.4%
Q2 24
24.0%
-10.7%
Net Margin
COFS
COFS
ORGO
ORGO
Q1 26
Q4 25
19.4%
Q3 25
23.7%
14.3%
Q2 25
22.4%
-9.3%
Q1 25
-31.0%
-21.7%
Q4 24
6.1%
Q3 24
20.1%
10.7%
Q2 24
19.4%
-13.1%
EPS (diluted)
COFS
COFS
ORGO
ORGO
Q1 26
Q4 25
$1.43
$0.31
Q3 25
$0.97
$0.11
Q2 25
$0.90
$-0.10
Q1 25
$-1.29
$-0.17
Q4 24
$0.79
$0.05
Q3 24
$0.85
$0.09
Q2 24
$0.87
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COFS
COFS
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$88.0M
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$465.4M
Total Assets
$4.4B
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COFS
COFS
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$88.0M
$93.7M
Q3 25
$99.0M
$63.7M
Q2 25
$156.3M
$73.1M
Q1 25
$139.4M
$110.0M
Q4 24
$96.8M
$135.6M
Q3 24
$145.9M
$94.3M
Q2 24
$101.0M
$89.9M
Total Debt
COFS
COFS
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
COFS
COFS
ORGO
ORGO
Q1 26
Q4 25
$465.4M
$300.1M
Q3 25
$449.6M
$255.1M
Q2 25
$431.8M
$233.2M
Q1 25
$427.1M
$242.9M
Q4 24
$260.4M
$262.9M
Q3 24
$247.7M
$278.5M
Q2 24
$214.5M
$263.5M
Total Assets
COFS
COFS
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$4.4B
$598.7M
Q3 25
$4.3B
$509.8M
Q2 25
$4.3B
$461.1M
Q1 25
$4.3B
$467.4M
Q4 24
$2.7B
$497.9M
Q3 24
$2.7B
$446.3M
Q2 24
$2.7B
$443.2M
Debt / Equity
COFS
COFS
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COFS
COFS
ORGO
ORGO
Operating Cash FlowLast quarter
$31.8M
Free Cash FlowOCF − Capex
$25.2M
FCF MarginFCF / Revenue
58.7%
Capex IntensityCapex / Revenue
15.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$38.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COFS
COFS
ORGO
ORGO
Q1 26
Q4 25
$31.8M
$39.4M
Q3 25
$15.3M
$3.1M
Q2 25
$9.0M
$-32.9M
Q1 25
$-6.5M
$-19.9M
Q4 24
$47.1M
$10.9M
Q3 24
$-7.4M
$8.7M
Q2 24
$15.7M
$4.7M
Free Cash Flow
COFS
COFS
ORGO
ORGO
Q1 26
Q4 25
$25.2M
$34.8M
Q3 25
$13.7M
$844.0K
Q2 25
$6.9M
$-36.5M
Q1 25
$-7.3M
$-23.6M
Q4 24
$45.4M
$7.6M
Q3 24
$-7.6M
$6.1M
Q2 24
$15.3M
$2.9M
FCF Margin
COFS
COFS
ORGO
ORGO
Q1 26
Q4 25
58.7%
15.4%
Q3 25
22.1%
0.6%
Q2 25
11.4%
-36.1%
Q1 25
-16.3%
-27.2%
Q4 24
186.4%
6.0%
Q3 24
-20.8%
5.3%
Q2 24
44.8%
2.2%
Capex Intensity
COFS
COFS
ORGO
ORGO
Q1 26
Q4 25
15.4%
2.1%
Q3 25
2.6%
1.5%
Q2 25
3.4%
3.6%
Q1 25
1.9%
4.2%
Q4 24
7.0%
2.7%
Q3 24
0.7%
2.2%
Q2 24
1.4%
1.4%
Cash Conversion
COFS
COFS
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
1.04×
0.14×
Q2 25
0.66×
Q1 25
Q4 24
1.43×
Q3 24
-1.00×
0.71×
Q2 24
2.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons